BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32205147)

  • 1. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
    Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
    Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
    Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
    Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
    Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary Fibrosis.
    Aussedat PH; Chebib N; Ahmad K; Glerant JC; Drevet G; Grima R; Maury JM; Nasser M; Thivolet-Bejui F; Traclet J; Turquier S; Chalabreysse L; Tronc F; Cottin V
    Respiration; 2020; 99(12):1101-1108. PubMed ID: 33260187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis.
    Yoo JW; Kim J; Song JW
    Sci Rep; 2022 May; 12(1):8817. PubMed ID: 35614114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis.
    Kondoh Y; Taniguchi H; Katsuta T; Kataoka K; Kimura T; Nishiyama O; Sakamoto K; Johkoh T; Nishimura M; Ono K; Kitaichi M
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(2):103-10. PubMed ID: 21319592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
    Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
    Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment.
    Kondoh Y; Taniguchi H; Ogura T; Johkoh T; Fujimoto K; Sumikawa H; Kataoka K; Baba T; Colby TV; Kitaichi M
    Respirology; 2013 Jul; 18(5):820-6. PubMed ID: 23489318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.
    Ohshimo S; Ishikawa N; Horimasu Y; Hattori N; Hirohashi N; Tanigawa K; Kohno N; Bonella F; Guzman J; Costabel U
    Respir Med; 2014 Jul; 108(7):1031-9. PubMed ID: 24835074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis.
    Matsuzawa Y; Kawashima T; Kuwabara R; Hayakawa S; Irie T; Yoshida T; Rikitake H; Wakabayashi T; Okada N; Kawashima K; Suzuki Y; Shirai K
    Pulm Pharmacol Ther; 2015 Jun; 32():1-6. PubMed ID: 25862941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.
    Kawamura K; Ichikado K; Ichiyasu H; Anan K; Yasuda Y; Suga M; Sakagami T
    BMC Pulm Med; 2019 Jun; 19(1):113. PubMed ID: 31238929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
    Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
    Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.